Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (251-260 of 459) with videos related to

Pageof 46
Sort By:
Cancers|January 21, 2023
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic ConsequencesMatteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, et al.
Cancers|July 24, 2021
Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not EnoughVeronica Mollica, Stefano Brocchi, Filippo Gustavo Dall'Olio, et al.
Translational Andrology and Urology|April 14, 2021
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative reviewAlessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Cancer Treatment Reviews|December 21, 2013
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature reviewRossana Berardi, Mariagrazia De Lisa, Silvia Pagliaretta, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Expert Review of Anticancer Therapy|June 19, 2013
Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectivesMatteo Santoni, Michele De Tursi, Alessandra Felici, et al.
Urologic Oncology|May 17, 2015
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasisAlessandro Conti, Matteo Santoni, Valeria Sotte, et al.
Journal of Nephrology|July 24, 2015
Renal cancer in kidney transplanted patientsGiovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
Future Oncology (London, England)|December 5, 2014
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practiceMaristella Bianconi, Matteo Santoni, Francesco Massari, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Pageof 46

Showing results (251-260 of 459) with videos related to

Sort By:
Pageof 46
Cancers|January 21, 2023
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic ConsequencesMatteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, et al.
Cancers|July 24, 2021
Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not EnoughVeronica Mollica, Stefano Brocchi, Filippo Gustavo Dall'Olio, et al.
Translational Andrology and Urology|April 14, 2021
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative reviewAlessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Cancer Treatment Reviews|December 21, 2013
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature reviewRossana Berardi, Mariagrazia De Lisa, Silvia Pagliaretta, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Expert Review of Anticancer Therapy|June 19, 2013
Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectivesMatteo Santoni, Michele De Tursi, Alessandra Felici, et al.
Urologic Oncology|May 17, 2015
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasisAlessandro Conti, Matteo Santoni, Valeria Sotte, et al.
Journal of Nephrology|July 24, 2015
Renal cancer in kidney transplanted patientsGiovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
Future Oncology (London, England)|December 5, 2014
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practiceMaristella Bianconi, Matteo Santoni, Francesco Massari, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Pageof 46